Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 1, 1997, Pages 1-8

  Suri, A ^a   Grundy, B L ^b   Derendorf, H ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Evoked potentials; Flurbiprofen; Ibuprofen; Pain measurement; Pharmacodynamic modeling; Pharmacokinetic

Indexed keywords

ANALGESIC AGENT; FLURBIPROFEN; IBUPROFEN;

ANALGESIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; ENANTIOMER; EVOKED RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; EVOKED POTENTIALS; FLURBIPROFEN; HUMANS; IBUPROFEN; PAIN MEASUREMENT; PLACEBOS; STEREOISOMERISM;

EID: 0031016570     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Adams SS, Cliffe EE, Lessel B, Nicholson JS 1967 Some biological properties of 2-(2-isobutylphenyl)-propionic acid. J Pharm Sci 56: 1686
2. Adams SS, Bresloff P, Mason CG 1976 Pharmacological differences between the optical isomers of ibuprofen: evidence for the metabolic inversion of the (-) isomer. J Pharm Pharmacol 28: 256-257
3. Brune K, Beck WS, Geisslinger G, Menzel S, Peskar, BM, Peskar BA 1991 Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experimentia 47: 257-261
4. Chapman CR, Chen ACN, Harkins SW 1979 Brain evoked potentials as correlates of laboratory pain: a review and perspective. In: Bonica JJ, Liebeskind JC, Albe-Fessard DG (eds) Advances in Pain Research and Therapy, Volume 3. Raven Press, New York, pp 791-803
5. Chatrian GE, Canfield RC, Knauss TA, Lettich E 1975 Cerebral responses to electrical tooth pulp stimulation in man: an objective correlate of acute experimental pain. Neurology 25: 745-757
6. Chen ACN, Chapman CR, Harkins SW 1979 Brain evoked potentials are functional correlates of induced pain in man. Pain 6: 365-374
7. Derendorf H, Drehsen G, Rohdewald P 1982 Cortical evoked potentials and saliva levels as basis for the comparison of pure analgesics to analgesic combinations. Pharmacology 25: 227-236
8. Derendorf H, Drehsen G, Rohdewald P 1984 Antipyrine: New light on an old drug. Pharm Res 5: 225-229
9. Geisslinger G, Ferreira SH, Menzel S, Schlott D, Brune K 1994a Antinociceptive actions of R(-)-flurbiprofen - a non-cycloxygenase inhibiting 2-arylpropionic acid - in rats. Life Sci 54: 173-177
10. Geisslinger G, Lötsch J, Menzel S, Kobal G, Brune K 1994b Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br J Clin Pharmacol 37: 392-394
11. Harkins SW, Chapman CR 1978 Cerebral evoked potentials to noxious dental stimulation: relationship to subjective pain report. Psychophysiology 15: 248-253
12. Holford NH, Sheiner LB 1981 Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6: 429-453
13. Holford NH, Sheiner LB 1982 Kinetics of pharmacologic response. Pharmacol Ther 16: 143-166
14. Hull CJ, van-Beem HBK, McLeod K, Sibbals V, Watson MJ 1978 A pharmacodynamic model for pancuronium. Br J Anaesthesia 50: 1113-1123
15. Hutt AJ, Caldwell J 1983 The metabolic chiral inversion of 2 aryl propionic acids: a novel route with pharmacological consequences. J Pharm Pharmacol 35: 693-704
16. Jamali F, Singh N, Pasutto FM, Russell AS 1988a Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates. Pharm Res 5: 40-43
17. Jamali F, Berry BW, Tehrani MR, Russell AS 1988b Stereoselective pharmacokinetics of Flurbiprofen in humans and rats. J Pharm Sci 77: 666-669
18. Knadler MP, Brater, DC, Hall SD 1992 Stereoselective disposition of Flurbiprofen in normal volunteers. Br J Clin Pharmacol 33: 369-375
19. Lee EJD, Williams K, Graham G, Champion D 1985 Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol 19: 669-674
20. Lemko CH, Caille G, Foster RT 1993 Stereospecific high-performance liquid chromatographic assay of Ibuprofen: improved sensitivity and sample processing efficiency. J Chromat 679: 330-335
21. Lötsch J, Geisslinger G, Mohammadian P, Brune K, Kobal G 1995 Effects of flurbiprofen enantiomers on pain-related chemosomatosensory evoked potetials in human subjects. Br J Clin Pharmacol 40: 339-346
22. Max MV, Laska EM 1991 Single dose analgesic comparisons. In: Max MB, Portenoy RK, Laska EM (eds) Advances in Pain Research and Therapy. Raven Press, New York, pp 55-95
23. Rohdewald P, Derendorf H, Drehsen G, Elger CE, Knoll O 1982a Changes in cortical evoked potentials as correlates of the efficacy of weak analgesics. Pain 12: 329-341
24. Rohdewald P, Derendorf H, Elger CE, Knoll O 1982b Evoked potentials as objective parameters for the analgesic response of weak analgesics. Adv Neurol 32: 375-381
25. Scientist 1993 User Handbook 1993. Micromath, Utah, pp 192-194
26. Scott J, Huskisson EC 1976 Graphic representation of pain. Pain 2: 175-184
27. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J 1979 Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 25: 358-371
28. Suri A, Grundy BL, Derendorf H 1996 Pharmacodynamic evaluation of codeine using tooth pulp evoked potential. J Clin Pharmacol (in press)